effects of stopping glp-1 medication Research cited in CNBC found that: • About 65% patients without diabetes stop medications within one year • Around 46% of patients with diabetes stop GLP-1 medications within one year Stopping GLP-1 drugs can quickly

Wellness is not a one-size-fits-all journey, and your unique biology plays a role in how you respond

Results vary, but Tesamorelin users often notice fat loss within a few months of consistent use

Patients should contact their healthcare provider if they experience recurrent dizziness or lightheadedness that interferes with daily activities, particularly if symptoms persist beyond the first few weeks of therapy or occur with each dose increase

Symptoms are more likely to appear or temporarily worsen when the dose is increased , which is expected and reflects how the body adjusts to higher levels of the medication rather than a sign that treatment is unsafe